High Adherence to Isoniazid for Tuberculosis Preventive Therapy among HIV-infected Persons in Chiang Rai, Thailand (Abstract 470) Jintana Ngamvithayapong-Yanai.

Slides:

Advertisements

Similar presentations

Tuberculosis in Children: Prevention Module 10C - March 2010.

Advertisements

Process and Products of TB/HIV Operational Research Chiang Rai, Thailand Jintana Ngamvithayapong-Yanai, PhD. JSPS-Fellow, Research Institute of Tuberculosis,

PMTCT FAILURE: THE ROLE OF MATERNAL AND FACILITY –RELATED FACTORS ICASA Presentation 8 th to 12 th Dec 2013 Onono Maricianah 1, Elizabeth A. Bukusi 1,

Health service utilization by patients with common mental disorder identified by the Self Reporting Questionnaire in a primary care setting in Zomba, Malawi.

FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.

Factors Associated with Interruption of Treatment Among Pulmonary Tuberculosis Patients in Plateau State, Nigeria, 2011 Luka M. Ibrahim 1, P. Nguku 1,

Jintana Ngamvithayapong-Yanai, PhD. JSPS-Fellow, Research Institute of Tuberculosis, Japan TB/HIV Research Foundation, Chiang Rai, Thailand 7 th International.

Unit 5: IPT Isoniazid TB Preventive Therapy

Jintana Ngamvithayapong-Yanai, Ph.D. On behalf of TB/HIV Working Group, the Asia-Pacific The 9 th International Congress on AIDS in Asia and the Pacific.

Can Research-Based Educational Material Increase Adherence to Tuberculosis Treatment among People with AIDS? Jintana Ngamvithayapong-Yanai, PhD. 1, 2 Sarmwai.

Violation of Rights of People Living with HIV/AIDS in Health Care Setting in Odessa, Ukraine Odessa, Ukraine August 2008 Kostiantyn Zverkov, Director of.

Module 14: Isoniazid Preventive Therapy Programme.

Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.

Unit 1: Overview of HIV/AIDS Case Reporting #6-0-1.

Management of the Newly Diagnosed Patient. Jane Bruton Clinical Research Nurse Imperial College.

The President’s Emergency Plan for AIDS Relief Next Generation Indicators.

Community Engagement in clinical trials Projet Ubuzima experience By Marie Michèle UMULISA Community Outreach & Recruitment Manager, Projet Ubuzima.

JNB/05 HIV/AIDS treatment - challenges in a remote rural area of Tanzania. Johan N. Bruun Department of Infectious Diseases Ullevål University Hospital.

Abbreviations: FGD = Focus Group Discussion INH = Isoniazid IPT = Isoniazid Preventive Therapy for TB PWH = People with HIV-infection DOT = Directly observed.

1 Assessing and Improving ARV Adherence HAIVN Harvard Medical School AIDS Initiative in Vietnam.

Nonadherence to HAART: A cross-sectional two-site hospital-based study Vivek Lal 1 ; Shashi Kant 2 ; Richa Dewan 3 ; Sanjay K. Rai 2 ; Ashutosh Biswas.

PROGRAM UPDATE OVERCOMING HIV/AIDS EPIDEMICS IN UKRAINE NATIONAL PROGRAM SUPPORTED BY GFATM COMPONENT: TREATMENT, CARE AND SUPPORT Presentation by Treatment,

Progress of the Singapore TB Elimination Programme (STEP)

6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,

Bi-national Commission for Collaboration on Health Guyana and Suriname. Presenter Mr. Nicholas Persaud –National HIV Care and Treatment Coordinator. Guyana.

The psychological and social sequela of HIV/AIDS infection are devastating to youth and their families. Individuals living with HIV/AIDS must cope with.

Community Empowerment for HIV or AIDS Care in Northern Thailand Pikul Nantachaipan Faculty of Nursing, Chiang Mai University, Thailand.

An approach for enabling schizophrenic in-patients to be discharge within three months Yoko NAKAYAMA, Michiko TANOUE, Junko NIMURA, Takako OHKAWA, Mayumi.

Objective: 1. To synthesize a series of published and non-published qualitative studies, conducted in Chiang Rai, Thailand between These qualitative.

Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho.

1 Mosby items and derived items © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier, Inc. Infection and Human Immunodeficiency Virus Infection Chapter.

Promoting Rational Use of ARVs in HIV/AIDS Clinics in Tanzania Presented by Salama Mwakisu -MSH.

Effect of community-wide isoniazid preventive therapy on tuberculosis among South African gold miners “Thibelo TB” Aurum Health Research LSHTM JHU Gold.

Module 2: Learning Objectives

Unit 5 Isoniazid Prevention Therapy: B Family Case Botswana National Tuberculosis Programme Manual Training for Medical Officers.

Improving Appointment Keeping and Adherence Monitoring In ART Facilities in Kenya: Views of Providers and Patients Susan Njogo National AIDS/STI Control.

Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.

Regulations 201: Thorny Issues What is Research? Exempt and Expedited Reviews.

Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.

TB Prevention and Control in Correctional and Detention Facilities Mark Lobato, MD Division of TB Elimination Centers for Disease Control and Prevention.

WAD SYMPOSIUM 2014 ART Adherence and Retention: MDH Experience Eric Aris Management and Development for Health 29 th November 2014 NJOMBE.

OUTCOME OF STAVUDINE INDUCED PERIPHERAL NEUROPATHY IN HIV-1 POSITIVE PATIENTS SWITCHED OR SUBSTITUTED TO A NON-STAVUDINE- BASED REGIMEN Dr P Gorejena-Chidawanyika.

Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,

MESSY SEMEN IN MATHARE SLUM: PROSPECTS OF POST EXPOSURE PROPHYLAXIS (PEP) By Eunice Owino.

SRHR Policy Salima 30 th June 2011 SRHR Policy Salima 30 th June 2011 Foundation for Children Rights.

Provider Initiated HIV Counseling and Testing Unit 2: Introduction and Rational for PIHCT.

Safety Monitoring & Adverse Drug Reactions to Efavirenz and INH Dr Clorata Gwanzura MBChB-UZ, MPH –FETP (UZ)

Home Based HIV Counseling and testing to optimize HIV identification, Kampala, Uganda Cecilia Nawavvu Co-authors Rhoda Wanyenze,

Thailand experience in implementing collaborative HIV/TB activities Anupong Chitwarakorn, MD Ministry of Public Health, Thailand TB/HIV Satellite symposium.

Keio University of School of Medicine

Tolerability of Isoniazid Preventive Therapy (IPT) in an HIV infected cohort

Validating Definitions of Antiretroviral Treatment Failure in Malawi

The association between nurses’ coordination with physicians and clients’ ability to die at home Takashi NARUSE, Natsuki YAMAMOTO, Takashi SUGIMOTO,

Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.

Don’t Nudge Me: The Limits of Behavioral Economics in Medicine

Quarraisha Abdool Karim, PhD

A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS

World Health Organization

Data Collection/Cleaning/Quality Processes MISAU Experience in Mozambique September 2017.

Mark Lobato, MD Division of TB Elimination

Factors Contributing To Delay In Key Populations Seeking Health Services: A Qualitative Study In Ghana By Abdulai Marijanatu Quaye Silas, Kenu Ernest,

Perceived barriers and facilitators to adherence to antiretroviral therapy among persons living with HIV in the Upper East Region Dr. Gifty Apiung Aninanya,

Tolerability of Isoniazid Preventive therapy Among HIV infected Cohort in Nigeria Folajinmi Oluwasina Strategic Information Unit AIDS Healthcare Foundation,

China 2010 UNGASS Country Progress Report

Enablers for nationwide expansion of collaborative TB/HIV activities

Integrated Biological and Behavioural Surveillance (IBBS) Survey among MSM in South Sudan 24 July 2018.

SEXUAL RISK BEHAVIOR OF PLWHA IN THE WA MUNICIPALITY

Experiences & outcomes of group psychotherapy as an antiretroviral adherence support intervention among young people failing ART at Newlands Clinic, Harare,

Community ART for Retention in Zambia: Fast Track Model

Public Health Implications

Presentation transcript:

High Adherence to Isoniazid for Tuberculosis Preventive Therapy among HIV-infected Persons in Chiang Rai, Thailand (Abstract 470) Jintana Ngamvithayapong-Yanai 1,2 Sarmwai Luangjina 1 Hideki Yanai 2 Pathom Sawanpanyalert 3 1 TB/HIV Research Foundation, Thailand, 2 The Research Institute of Tuberculosis, JATA, Japan, 3 Ministry of Public Health, Thailand Supported by Japanese Foundation for AIDS Prevention (JFAP) and Ministry of Health, Welfare and Labor, Japan

Abbreviations FGD = Focus group discussion INH = Isoniazid IPT = Isoniazid Preventive Therapy for Tuberculosis PWH = People with HIV infection (asymptomatic stage) Objective To investigate the reasons for a high level of adherence to the nine-month IPT

Regimen Daily 300 mg. Of INH and vitamin B complex for 9 months (one month supply) Clients and setting PWH (recruited from blood donors, outpatients clinic, anonymous HIV testing clinics and sex workers) Chiang Rai Regional Hospital Definition “High level of adherence” = clients who took % of INH of the total number of prescribed INH pills in 9 months

Methods of assessing adherence to IPT 1. Quantitative assessment -To know the level of adherence 2. Qualitative assessment - To know the reasons why a group of PWH could achieve a high level of adherence although they were in “asymtomatic stage of HIV infection” and AIDS stigma is a problem in the study setting. This paper discuss about qualitative assessment of adherence to IPT with special emphasis on “high level of adherence”

Methods of assessing adherence to IPT 1. Measuring the level of adherence pill counting Adherence % = no.of prescribed INH taken by the client X 100 no.of INH prescribed for the client patient self-report measure of appointment kept 2. Assessing reasons for high level of adherence FGD with the clients who achieved a high level of adherence.

Method: Selection of FGD participants PHA participated in the IPT program = 412 PHA achieved a high level of adherence = 42 PHA participated in the FGD = 28 1 group of single males 2 groups of married males 1 group of married females 1 group of widowed females Grouping based on homogeneous attributes

Strength and limitation of FGD Limitation: Some participants did not want to open themselves to other members of the groups due to HIV/AIDS stigma. Therefore, reasons and methods for achieving a high level of adherence to IPT of these participants are not known

Strength and limitation of FGD Strength: The five sessions of FGD were conducted by the same moderator -- increase validity of the data Interactions among the participants generated rich information which can not be obtained by individual interview Provided rich information from a group of people quickly with less cost

Recommendations The paper highlights two methodological aspects of research on adherence: 1. Assessing reasons for “good adherence” rather than “non-adherence” which many studies have done. The results are applicable to improve adherence in other settings 2. FGD is a promising tool for qualitative assessment of adherence to treatment

Acknowledgement Japanese Foundation for AIDS Prevention (JFAP) and Ministry of Health, Welfare and Labor, Japan supported the study Dr.Renu Srismith, Dr.Wat Uthaivoravit and staff nurses of Social Preventive Medicine Department, Chiang Rai Hospital for approval the study and their kind collaboration. All participants kindly participated in the focus group discussion